Contact Us
Company Science Products Careers Contact Us
Anand Singh Thakur

Anand Singh Thakur

Founder, Chairman & Managing Director

Anand is a high-impact pharmaceutical entrepreneur and growth strategist with a 25-year track record of scaling organisations within the global life sciences sector. As the Founder and Chairman of INVIVO, he provides the overarching vision for the enterprise, integrating technical mastery with a strong focus on global commercial expansion.

His career includes leadership roles at premier multinational organisations such as Biocon Ltd. and Dr. Reddy’s Laboratories, where he played a key role in bridging innovative R&D with high-yield commercial manufacturing.

Anand’s contribution to INVIVO’s rapid growth is driven by his extensive global network of customers, distributors, and pharmaceutical professionals. This ecosystem enables accelerated market entry and direct access to decision-makers across MEA, ASEAN, LATAM, and CIS regions.

His expertise in strategic partnerships has led to high-value collaborations with CDMOs and supply chain networks, ensuring sustainable growth and strong stakeholder engagement across global markets.

An expert in asset and infrastructure development, he has led the execution of greenfield and brownfield manufacturing facilities, transforming complex engineering concepts into high-value operational assets.

With a Master’s degree in Chemistry and an MBA in Marketing & Operations, Anand brings a rare combination of scientific insight and commercial acumen, enabling effective lifecycle management and ROI optimization.

Under his leadership, INVIVO is positioned as a globally connected pharmaceutical powerhouse, committed to redefining healthcare accessibility through innovation and strategic market leadership.

Founder’s Vision: Disrupting the Barrier to Health

"At INVIVO, we do not accept the status quo where life-saving medicine is a privilege of geography or wealth. My vision—and the fundamental purpose of this organisation—is to dismantle the cost barriers that stand between patients and the treatments they deserve. We are not just manufacturing pharmaceuticals; we are engineering a more equitable global healthcare ecosystem."

— Anand Singh